Search results for “Glycopeptide” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 2,372 patents, we discovered top 437 key players by total patent application. Eli Lilly & Co., Cumberland Pharmaceuticals, Inc., Theravance Biopharma Antibiotics IP LLC are dominant in this area. They take 16.69% of the total patent filing.
Indiana, United States
Patent: 240
Tennessee, United States
Patent: 79
Delaware, United States
Patent: 77
California, United States
Patent: 63
Hovedstaden, Denmark
Patent: 62
Osaka-fu, Japan
Patent: 58
STARTUP
California, United States
Patent: 34
Ohio, United States
Patent: 33
Tokyo-to, Japan
Patent: 33
New Jersey, United States
Patent: 33
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 86 patents, we discovered top 9 start-ups by total patent application. Venn Biosciences Corp., SyntheX, Inc., Institut National de la Santé et de la Recherche Médicale are active in this area.
STARTUP
California, United States
Patent: 34
STARTUP
California, United States
Patent: 21
STARTUP
France
Patent: 11
STARTUP
Vaud, Switzerland
Patent: 8
STARTUP
Massachusetts, United States
Patent: 6
STARTUP
California, United States
Patent: 2
STARTUP
New Jersey, United States
Patent: 2
STARTUP
Sachsen, Germany
Patent: 1
STARTUP
New York, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 669 patents applied in the last 5 years. We discover 257 most active companies in this area. The fast-growing Venn Biosciences Corp., Insmed, Inc., Max Planck Gesellschaft zur Förderung der Wissenschaften eV take 12.86% of patent filing during this period.
STARTUP
California, United States
Patent: 34
New Jersey, United States
Patent: 27
Bayern, Germany
Patent: 25
New York, United States
Patent: 24
Liaoning Sheng, China
Patent: 21
Ohio, United States
Patent: 16
Ningxia Huizi Zizhiqu, China
Patent: 13
Ningxia Qi Peptide Technology Co., Ltd.
Ningxia Huizi Zizhiqu, China
Patent: 11
Jiangsu Sheng, China
Patent: 10
Central Singapore, Singapore
Patent: 10
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 669 patents in last 5 years, we discover 177 new entrants. Venn Biosciences Corp., Max Planck Gesellschaft zur Förderung der Wissenschaften eV, Regeneron Pharmaceuticals, Inc. are the most active new entrants in this area.
STARTUP
California, United States
Patent: 34
Bayern, Germany
Patent: 25
New York, United States
Patent: 24
Ningxia Qi Peptide Technology Co., Ltd.
Ningxia Huizi Zizhiqu, China
Patent: 11
Jiangsu Sheng, China
Patent: 8
Hebei Sheng, China
Patent: 8
STARTUP
Vaud, Switzerland
Patent: 8
Hano Biotechnology (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 5
China
Patent: 5
Cellkey, Inc.
South Korea
Patent: 4
Research Institutions
Order by:
Innovation Intensity
With the analysis among 1,087 patents, we discovered top 155 universities and scientific research institutions by total patent application. Dalian Institute of Chemical Physics Chinese Academy of Sciences, Fudan University, Hokkaido University are dominant in this area. They take 18.22% of the total patent filing.
Liaoning Sheng, China
Patent: 53
Shanghai Shi, China
Patent: 25
Hokkaido, Japan
Patent: 23
California, United States
Patent: 18
New Jersey, United States
Patent: 15
Texas, United States
Patent: 13
Queensland, Australia
Patent: 12
Hovedstaden, Denmark
Patent: 11
Jiangsu Sheng, China
Patent: 11
California, United States
Patent: 11
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: